logo
  

Bayer Reports Successful Start To FY21; Proposes Dividend

Bayer AG (BAYZF.PK,BAYRY.PK,BYR.L) Tuesday said it continues to expect the year 2021 to be a transition year, but early indications were of a successful start to the year.

In the agriculture business, in particular, the company sees a market environment that gives an increasingly positive perspective.

At the Annual Stockholders' Meeting, CEO Werner Baumann said, "...we are active in the right industries. After all, few things are more important to people than health and nutrition. And that's where we can make a decisive contribution. We're optimistic for the future."

Further, Baumann emphasized that all three of Bayer's divisions are set to grow and increase their earning power, reconfirming the mid-term targets presented by the Board of Management at the Capital Markets Day in March.

Despite certain extraordinary charges, Bayer is maintaining its dividend policy of distributing between 30 and 40 percent of core earnings per share. The Board of Management and Supervisory Board have proposed to the Annual Stockholders' Meeting that a dividend of 2.00 euros per share entitled to the dividend be paid for fiscal 2020.

In Germany, Bayer shares were trading at 54.25 euros, down 1.06 percent.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Viona Pharmaceuticals Inc. has recalled type 2 diabetes drug Metformin in the form of oral film-coated tablets for the potential presence of nitrosamine impurity, N-Nitrosodimethylamine (NDMA), above levels of the Acceptable Daily Intake Limit (ADI), the U.S. Food and Drug Administration or FDA said in a statement. Ford Motor Co. on Monday issued a recall for a total of 19,626 2021 F-Series Super Duty vehicles with dual rear wheels in North America. These include 17,616 vehicles in the U.S. and federal territories; 1,779 in Canada; and 231 in Mexico. The affected vehicles are equipped with front-wheel hub extenders... Royal Philips has recalled specific sleep and respiratory care devices due to the potential health risks related to the polyester-based polyurethane or PE-PUR sound abatement foam component. The affected products include Bi-Level Positive Airway Pressure or Bi-Level PAP, Continuous Positive Airway Pressure or CPAP, and mechanical ventilator devices.
Follow RTT